FDA Patient, Consumer Reps Often Tied To Pharma-Funded Groups

WEDNESDAY, Oct. 21, 2026— Patient and consumer representatives advising U.S. Food and Drug Administration (FDA) expert panels might actually be a Trojan horse for the pharmaceutical industry, a new study says.These supposedly average-Joe...